Seagen Inc Revenue per Employee (SGEN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Seagen Inc   (NASDAQ: SGEN)
 

Seagen Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 27.11% in the third quarter 2023, year on year to cumulative value of $2,300 million, Seagen Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,916,959, this is below the company average.
Within the Healthcare sector Employees of 13 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 247, from total ranking in previous quarter at 251. Seagen Inc has 1,200 employees.


What is Sales per Employee Ratio?







SGEN Revenue per Employee (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change 27.11 % 21.37 % 21.87 % 22.87 % 20.34 %
Sales per Employee (TTM) $ 1,916,959 1,801,668 1,713,059 1,635,343 1,553,427
SGEN's Total Ranking # 247 # 251 # 133 # 0 # 0
Seq. Revenue Change 7.42 % 16.18 % -1.6 % 3.5 % 2.57 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 14
Overall Market # 247

Revenue per Employee Statistics
High Average Low
$ 882,772 $ 364,196 $ 99,727
(Jun 30 2021)   (Dec 31 2013)



Financial Statements
Seagen Inc 's Revenue MRQ $ 649 Millions Visit SGEN's Income Statement
Seagen Inc 's Revenues TTM $ 2,300 Millions Visit SGEN's aggregate revenue growth
What are SGEN's Sales? Visit SGEN's Sales by Segment




Other Ratios
Seagen Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SGEN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SGEN's Competitors
Revenue per Employee for SGEN's Suppliers
Revenue per Employee for SGEN's Customers

You may also want to know
SGEN's Sales Growth Rates SGEN's Pe Price to earnings ratio SGEN's Receivables Turnover Ratio SGEN's Stock Quote
SGEN's Net Income Growth Rates SGEN's Ps Price to Sales ratio SGEN's Sales per Employee SGEN's Asset Turnover Ratio
SGEN's Net Margin SGEN's Pb Price to Book ratio SGEN's Financial Strength Ratios SGEN's Dividend Payout Ratio
Date modified: 2026-08-29T17:24:33+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2023Number of Employees Sep 30 2023
Prophase Labs Inc   3,258,000.00 $ 61.902  Million 19 
Assertio Holdings inc   3,196,924.53 $ 169.437  Million 53 
Spero Therapeutics Inc   3,107,960.00 $ 77.699  Million 25 
Equillium Inc   3,045,142.86 $ 42.632  Million 14 
Ligand Pharmaceuticals Incorporated  2,771,446.81 $ 130.258  Million 47 
Akumin Inc   2,762,887.64 $ 737.691  Million 267 
Arcturus Therapeutics Holdings Inc   2,668,801.80 $ 296.237  Million 111 
Shockwave Medical Inc   2,649,292.49 $ 670.271  Million 253 
Telesis Bio Inc   2,515,454.55 $ 27.670  Million 11 
Cue Health Inc   2,486,437.50 $ 198.915  Million 80 
Point Biopharma Global Inc   2,436,926.76 $ 243.693  Million 100 
Xeris Biopharma Holdings Inc   2,348,738.46 $ 152.668  Million 65 
Petros Pharmaceuticals inc   2,328,243.33 $ 6.985  Million
Amylyx Pharmaceuticals Inc   2,163,397.06 $ 294.222  Million 136 
Semler Scientific inc   2,158,774.19 $ 66.922  Million 31 
Prothena Corporation Public Limited Company  2,104,134.33 $ 140.977  Million 67 
Intra cellular Therapies Inc   2,079,900.99 $ 420.140  Million 202 
Amgen Inc   2,064,076.92 $ 26,833.000  Million 13,000 
Opus Genetics Inc   2,043,142.86 $ 57.208  Million 28 
Prestige Consumer Healthcare Inc   1,975,589.47 $ 1,126.086  Million 570 
Therapeuticsmd Inc   1,952,000.00 $ 1.952  Million
Moderna Inc   1,940,638.30 $ 9,121.000  Million 4,700 
Seres Therapeutics Inc   1,927,818.18 $ 127.236  Million 66 
Seagen Inc   1,916,959.17 $ 2,300.351  Million 1,200 
Catalyst Pharmaceuticals Inc   1,914,247.25 $ 348.393  Million 182 
Harmony Biosciences Holdings inc   1,848,539.25 $ 541.622  Million 293 
Halozyme Therapeutics Inc   1,845,650.12 $ 780.710  Million 423 
Marker Therapeutics inc   1,812,748.60 $ 9.064  Million
Innoviva Inc   1,803,572.33 $ 286.768  Million 159 
Tvardi Therapeutics Inc   1,768,750.00 $ 21.225  Million 12 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.